Cronos (CRON) Change in Receivables (2020 - 2026)
Cronos (CRON) posted quarterly Change in Receivables of -$879000.0 for Q1 2026, down 125.78% year-over-year from $3.4 million in Q1 2025, and down 114.11% quarter-over-quarter from $6.2 million in Q4 2025.
Cronos (CRON) Change in Receivables (2020 - 2026) Analysis & Trends
Cronos' Change in Receivables history runs 7 years deep, the most recent figure standing at -$879000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 125.78% year-over-year to -$879000.0; the TTM figure through Mar 2026 stood at $12.5 million (up 366.06% YoY), while the FY2025 annual figure was $16.7 million, up 1725.63% from the prior year.
- Change in Receivables for Q1 2026 stood at -$879000.0, down from $6.2 million in the prior quarter.
- The five-year high for Change in Receivables was $6.4 million in Q2 2025, with the low at -$8.2 million in Q1 2023.
- The 5-year median for Change in Receivables is $1.1 million (2024), against an average of $604941.2.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables sank 332.32% in 2023, then surged 497.29% in 2025.
- Cronos' Change in Receivables stood at $3.9 million in 2022, then sank by 157.43% to -$2.2 million in 2023, then sank by 101.12% to -$4.5 million in 2024, then jumped by 238.93% to $6.2 million in 2025, then slumped by 114.11% to -$879000.0 in 2026.
- Business Quant data shows CRON's Change in Receivables at -$879000.0 in Q1 2026, $6.2 million in Q4 2025, and $716000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 3.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.57 Mn |
| Jun 30, 2026 | 3.57 Mn |
| Mar 31, 2026 | -879,000.00 |
| Mar 31, 2026 | -879,000.00 |
| Dec 31, 2025 | 6.23 Mn |
| Dec 31, 2025 | 6.23 Mn |
| Sep 30, 2025 | 716,000.00 |
| Sep 30, 2025 | 716,000.00 |
| Jun 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 6.39 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | -4.49 Mn |
| Dec 31, 2024 | -4.49 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.65 Mn |